Evogene (TSE:EVGN) Rating Lowered to Sector Perform at Royal Bank of Canada

Evogene (TSE:EVGNGet Rating) was downgraded by equities research analysts at Royal Bank of Canada from an “outperform” rating to a “sector perform” rating in a research report issued on Wednesday, BayStreet.CA reports. They presently have a C$3.00 target price on the stock, down from their previous target price of C$5.00.

Separately, Pi Financial reduced their price target on shares of Evogene from C$8.25 to C$8.00 in a research report on Wednesday.

Evogene Stock Performance

About Evogene

(Get Rating)

Evogene is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its broadly applicable Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and guide the development of life-science products based on microbes, small molecules and genetic elements.

Featured Stories

Receive News & Ratings for Evogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evogene and related companies with MarketBeat.com's FREE daily email newsletter.